Release Date: 29/10/18 15:08 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 611.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%